TW201613574A - Use of a composition containing 4-acetyl-antroquinonol B for preparing pharmaceutical compositions for inhibiting growth of cancer cells - Google Patents

Use of a composition containing 4-acetyl-antroquinonol B for preparing pharmaceutical compositions for inhibiting growth of cancer cells

Info

Publication number
TW201613574A
TW201613574A TW103135386A TW103135386A TW201613574A TW 201613574 A TW201613574 A TW 201613574A TW 103135386 A TW103135386 A TW 103135386A TW 103135386 A TW103135386 A TW 103135386A TW 201613574 A TW201613574 A TW 201613574A
Authority
TW
Taiwan
Prior art keywords
antroquinonol
acetyl
cancer cells
pharmaceutical compositions
composition containing
Prior art date
Application number
TW103135386A
Other languages
Chinese (zh)
Other versions
TWI542348B (en
Inventor
Chun-Chih Huang
Yew-Min Tzeng
Chi-Tai Yeh
Tsang-Hsien Alexander Wu
Original Assignee
New Bellus Entpr Co Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by New Bellus Entpr Co Ltd filed Critical New Bellus Entpr Co Ltd
Priority to TW103135386A priority Critical patent/TWI542348B/en
Publication of TW201613574A publication Critical patent/TW201613574A/en
Application granted granted Critical
Publication of TWI542348B publication Critical patent/TWI542348B/en

Links

Landscapes

  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)

Abstract

The present invention is directed to a use of a composition for preparing a pharmaceutical composition for the inhibition growth of cancer cells, wherein the composition comprising an effective amount of a compound of formula I (4-acetyl-antroquinonol B) or pharmaceutical acceptable salts thereof, together with an anti-cancer drug and a pharmaceutically acceptable carrier.
TW103135386A 2014-10-13 2014-10-13 Use of a composition containing 4-acetyl-antroquinonol b for preparing pharmaceutical compositions for inhibiting growth of cancer cells TWI542348B (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
TW103135386A TWI542348B (en) 2014-10-13 2014-10-13 Use of a composition containing 4-acetyl-antroquinonol b for preparing pharmaceutical compositions for inhibiting growth of cancer cells

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
TW103135386A TWI542348B (en) 2014-10-13 2014-10-13 Use of a composition containing 4-acetyl-antroquinonol b for preparing pharmaceutical compositions for inhibiting growth of cancer cells

Publications (2)

Publication Number Publication Date
TW201613574A true TW201613574A (en) 2016-04-16
TWI542348B TWI542348B (en) 2016-07-21

Family

ID=56361063

Family Applications (1)

Application Number Title Priority Date Filing Date
TW103135386A TWI542348B (en) 2014-10-13 2014-10-13 Use of a composition containing 4-acetyl-antroquinonol b for preparing pharmaceutical compositions for inhibiting growth of cancer cells

Country Status (1)

Country Link
TW (1) TWI542348B (en)

Cited By (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
TWI607752B (en) * 2016-08-19 2017-12-11 麗豐實業股份有限公司 Use of a composition containing 4-acetyl-antroquinonol b for preparing pharmaceutical compositions for inhibiting growth of ovarian cancer cells
WO2023030043A1 (en) * 2021-08-30 2023-03-09 珂阑(上海)医药科技有限公司 Tricyclic diterpene analogue, and synthesis and application thereof

Cited By (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
TWI607752B (en) * 2016-08-19 2017-12-11 麗豐實業股份有限公司 Use of a composition containing 4-acetyl-antroquinonol b for preparing pharmaceutical compositions for inhibiting growth of ovarian cancer cells
WO2023030043A1 (en) * 2021-08-30 2023-03-09 珂阑(上海)医药科技有限公司 Tricyclic diterpene analogue, and synthesis and application thereof

Also Published As

Publication number Publication date
TWI542348B (en) 2016-07-21

Similar Documents

Publication Publication Date Title
PH12018500591A1 (en) Heterocyclic compounds and uses thereof
PH12015501996A1 (en) Heterocyclic compounds and uses thereof
MX2019009932A (en) Quinazoline derivatives used to treat hiv.
TW201613911A (en) Heterocyclic compounds and uses thereof
PH12016500467A1 (en) Aminoheteroarlyl benzamides as kinase inhibitors
MD20170016A2 (en) Aminopyrimidinyl compounds as JAK inhibitors
GEP20186933B (en) Substituted dihydroisoquinoline compounds
NZ716840A (en) Combination formulation of two antiviral compounds
MY197698A (en) Oxysterols and methods of use thereof
MD4684B1 (en) Imidazopyrazine-based formulations as SYK inhibitors
PH12016501462A1 (en) Neprilysin inhibitors
PH12018500378B1 (en) Novel annelated phenoxyacetamides
TW201613864A (en) Novel compounds
PH12016502130B1 (en) Novel pyrrolopyrimidine compound or salt thereof, pharmaceutical composition containing same, especially agent for prevention and/or treatment of tumors etc based on nae inhibitory effect
PH12018500377A1 (en) Novel annelated benzamides
NZ710291A (en) 2-substituted-6-biarylmethylamino-9-cyclopentyl-9h-purine derivatives, use thereof as medicaments, and pharmaceutical compositions
PH12018501709A1 (en) Naphthridinedione derivatives
MX2016003522A (en) Quinazoline derivatives and their use as dna methyltransferase inhibitors.
PH12016501997A1 (en) Cycloalkyl-linked diheterocycle derivatives
TW201613574A (en) Use of a composition containing 4-acetyl-antroquinonol B for preparing pharmaceutical compositions for inhibiting growth of cancer cells
MX2017002627A (en) Derivatives of macrocyclic n-aryl-2-amino-4-aryl-pyrimidine polyethers as inhibitors of ftl3 and jak.
MX2017002747A (en) Derivatives of macrocyclic n-aryl-tricyclopyrimidine-2-amine polyethers as inhibitors of ftl3 and jak.
EA201891136A1 (en) PHARMACEUTICAL COMPOSITION CONTAINING AS A ACTIVE INGREDIENT DERIVATIVE 7-AZAINDOLIN-2-SHE OR ITS PHARMACEUTICALLY ACCEPTABLE SALT